Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15911865 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: cisplatin;   Drug: topotecan hydrochloride

Indicates status has not been verified in more than two years